On September 2, technical director Wu Lan presented IVRT and IVPT methods and regulatory considerations to researchers from Hanxin and Letao Biotech.
Read the original company report ↗HANXIN NEWS
Technical Seminar on IVPT, IVRT and Regulatory Requirements

Meet the sales team
